BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31308480)

  • 1. Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease.
    Karmele EP; Pasricha TS; Ramalingam TR; Thompson RW; Gieseck RL; Knilans KJ; Hegen M; Farmer M; Jin F; Kleinman A; Hinds DA; ; Almeida Pereira T; de Queiroz Prado R; Bing N; Tchistiakova L; Kasaian MT; Wynn TA; Vannella KM
    Mucosal Immunol; 2019 Sep; 12(5):1174-1186. PubMed ID: 31308480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease.
    Verstockt B; Perrier C; De Hertogh G; Cremer J; Creyns B; Van Assche G; Ferrante M; Ceuppens JL; Vermeire S; Breynaert C
    Front Immunol; 2018; 9():2983. PubMed ID: 30619339
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanical stretch and angiotensin II increase interleukin-13 production and interleukin-13 receptor alpha2 expression in rat neonatal cardiomyocytes.
    Nishimura Y; Inoue T; Morooka T; Node K
    Circ J; 2008 Apr; 72(4):647-53. PubMed ID: 18362439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis.
    Lenzen H; Qian J; Manns MP; Seidler U; Jörns A
    J Mol Med (Berl); 2018 Aug; 96(8):831-843. PubMed ID: 29967942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-13 receptor α2 contributes to development of experimental allergic asthma.
    Chen W; Sivaprasad U; Gibson AM; Ericksen MB; Cunningham CM; Bass SA; Kinker KG; Finkelman FD; Wills-Karp M; Khurana Hershey GK
    J Allergy Clin Immunol; 2013 Oct; 132(4):951-8.e1-6. PubMed ID: 23763980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts.
    Takenouchi M; Hirai S; Sakuragi N; Yagita H; Hamada H; Kato K
    Clin Cancer Res; 2011 May; 17(9):2819-29. PubMed ID: 21357681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts.
    Barnes JC; Lumsden RV; Worrell J; Counihan IP; O'Beirne SL; Belperio JA; Fabre A; Donnelly SC; Boylan D; Kane R; Keane MP
    Am J Respir Cell Mol Biol; 2015 Aug; 53(2):217-25. PubMed ID: 25514189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway.
    Mandal D; Levine AD
    Inflamm Bowel Dis; 2010 May; 16(5):753-64. PubMed ID: 20014020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's-like disease in a patient exposed to anti-Interleukin-17 blockade (Ixekizumab) for the treatment of chronic plaque psoriasis: a case report.
    Smith MK; Pai J; Panaccione R; Beck P; Ferraz JG; Jijon H
    BMC Gastroenterol; 2019 Sep; 19(1):162. PubMed ID: 31488067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms.
    Tabata Y; Chen W; Warrier MR; Gibson AM; Daines MO; Hershey GK
    J Immunol; 2006 Dec; 177(11):7905-12. PubMed ID: 17114462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis.
    Tang B; Zhu J; Zhang B; Wu F; Wang Y; Weng Q; Fang S; Zheng L; Yang Y; Qiu R; Chen M; Xu M; Zhao Z; Ji J
    Front Immunol; 2020; 11():592084. PubMed ID: 33240279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis.
    Colombo G; Clemente N; Zito A; Bracci C; Colombo FS; Sangaletti S; Jachetti E; Ribaldone DG; Caviglia GP; Pastorelli L; De Andrea M; Naviglio S; Lucafò M; Stocco G; Grolla AA; Campolo M; Casili G; Cuzzocrea S; Esposito E; Malavasi F; Genazzani AA; Porta C; Travelli C
    J Mol Med (Berl); 2020 Apr; 98(4):595-612. PubMed ID: 32338310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.
    Wilson MS; Ramalingam TR; Rivollier A; Shenderov K; Mentink-Kane MM; Madala SK; Cheever AW; Artis D; Kelsall BL; Wynn TA
    Gastroenterology; 2011 Jan; 140(1):254-64. PubMed ID: 20951137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement component 6 deficiency increases susceptibility to dextran sulfate sodium-induced murine colitis.
    Ding P; Li L; Huang T; Yang C; Xu E; Wang N; Zhang L; Gu H; Yao X; Zhou X; Hu W
    Immunobiology; 2016 Nov; 221(11):1293-303. PubMed ID: 27316715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-13 receptor isoforms: breaking through the complexity.
    Tabata Y; Khurana Hershey GK
    Curr Allergy Asthma Rep; 2007 Sep; 7(5):338-45. PubMed ID: 17697639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel interleukin-13 receptor alpha 2-targeted hybrid peptide for effective glioblastoma therapy.
    Kurihara R; Horibe T; Shimizu E; Torisawa A; Gaowa A; Kohno M; Kawakami K
    Chem Biol Drug Des; 2019 Jul; 94(1):1402-1413. PubMed ID: 30903640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin.
    Kioi M; Seetharam S; Puri RK
    Mol Cancer Ther; 2008 Jun; 7(6):1579-87. PubMed ID: 18566228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes.
    Ulzii D; Kido-Nakahara M; Nakahara T; Tsuji G; Furue K; Hashimoto-Hachiya A; Furue M
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the IL-33/IL-13 Axis in Obesity by IL-13Rα2.
    Duffen J; Zhang M; Masek-Hammerman K; Nunez A; Brennan A; Jones JEC; Morin J; Nocka K; Kasaian M
    J Immunol; 2018 Feb; 200(4):1347-1359. PubMed ID: 29305434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of Herbal Formulation for Inflammatory Bowel Disease Based on In Vitro Screening and In Vivo Evaluation in a Mouse Model of Experimental Colitis.
    Lee J; Choi HS; Lee J; Park J; Kim SB; Shin MS; Lee S; Hwang GS; Koo BA; Kang KS
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30696085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.